Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Vote In favor of Your Favored Web based Dating Application - 2Islamic State group militants claim capture and execution of a Nigerian brigadier general
- 3They grew up with 'almond moms.' Now, they dread going home for the holidays.
- 4Italy's Beloved Trevi Fountain Hides A Unique Secret That Can Be Explored Underground
- 5New science points to 4 distinct types of autism
- Midlife weight gain can start long before menopause – but you can take steps early on to help your body weather the hormonal shift
- Remains of banker missing since 1999 found on California beach by family looking for seashells
- Factbox-Artemis II crew includes first woman, Black astronaut and Canadian ever flown to moon
- ‘Serving is not just a place’: Bayside Church Granite Bay reimagines annual mission amid conflict in Mexico
- Old video misrepresented as senior Sri Lankan ruling party member criticising president over fuel shortage
- Find the Mysteries of Powerful Using time productively: Augmenting Efficiency and Proficiency
- Historical mysteries solved by science in 2025
- ‘Aid for Ukraine’ pierogi fundraiser event
- Space Condos to Lift Your Metropolitan Living
